New Federal Contractors — August 12, 2026

Leidos' QTC Medical Services won a $113.9M firm-fixed-price delivery order from the VA for medical disability exams in the Midwest, with $104.6M already outlaid. The high outlay rate signals strong execution and recurring revenue from a legally mandated program (Veterans Benefits Improvement Act).

Palmetto GBA's 16-year, $212.5M cost-plus-award-fee contract with CMS has only $14.6M outlaid through September 2024. The large gap between obligated and disbursed funds suggests either slow execution, funding delays, or pending re-compete risk.

Jacobs Engineering secured a $105.6M firm-fixed-price BPA call from CBP for construction management on 11 border patrol stations, with potential value up to $162.3M through 2031. The firm-fixed-price structure carries execution risk on design-build projects.

Hoffmann-La Roche (Roche) secured a $183.8M cost-no-fee contract from BARDA for biotechnology R&D through 2028. The cost-no-fee structure limits revenue upside but provides predictable reimbursement for biodefense R&D.

Jacobs Engineering faces execution risk on 11 design-build border patrol station projects under a firm-fixed-price contract. Cost overruns could compress margins on the $105.6M base award.

Palmetto GBA's CMS contract expires September 2024 with only 7% of obligated funds disbursed. If not renewed or re-competed, the remaining $197.9M may not materialize, impacting Palmetto GBA's revenue expectations.

Leidos' QTC Medical Services derives $113.9M from a single VA delivery order. While the VA is a stable budget environment, any policy changes to the Veterans Benefits Improvement Act could reduce demand for disability exams.

Leidos' QTC Medical Services can expand its VA disability exam market share by winning similar delivery orders in other regions. The 92% outlay rate on the Midwest contract demonstrates strong performance credentials.

Jacobs Engineering can grow its DHS/CBP relationship by exercising options on the $105.6M border station contract, potentially increasing total value to $162.3M. Border security infrastructure remains a bipartisan funding priority.

Roche's BARDA contract positions it for follow-on biodefense R&D awards, especially given the long-term (12-year) performance period. Option exercises could increase the $183.8M base obligation.

Two of four contracts ($396.4M total) are with HHS agencies (CMS and BARDA), highlighting sustained federal investment in healthcare administration and biodefense R&D. Palmetto GBA's 16-year CMS contract and Roche's 12-year BARDA award demonstrate multi-decade program durability.

Jacobs Engineering's $105.6M CBP contract for 11 border patrol stations signals sustained DHS investment in physical infrastructure. The 5-year performance period and option structure provide multi-year revenue visibility.

{"entity" => "Palmetto GBA, LLC", "reason" => "CMS contract expires September 2024 with only 7% disbursed; re-compete or renewal decision is imminent.", "trigger" => "CMS solicitation for National Supplier Clearinghouse re-compete or contract extension announcement"}

{"entity" => "Leidos Holdings (LDOS)", "reason" => "QTC Medical Services' 92% outlay rate on VA contract suggests strong execution; watch for regional expansion.", "trigger" => "VA solicitation for disability exam services in new regions or QTC's win rate in future competitions"}

{"entity" => "Jacobs Engineering Group Inc.", "reason" => "Option exercise on $105.6M CBP contract could add $56.7M in value; execution on design-build projects is critical.", "trigger" => "CBP announcement of option exercise or project milestone completions"}

{"entity" => "Roche Holding (RHHBY)", "reason" => "BARDA contract options could increase R&D funding; monitor for pandemic preparedness policy shifts.", "trigger" => "BARDA option exercise announcements or new biodefense funding legislation"}